Yew Bio Pharm Revenue, Profits - YEWB Quarterly Income Statement

Add to My Stocks
$0.37 $0 (0%) YEWB stock closing price Apr 20, 2018 (Closing)

YEWB stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Yew Bio Pharm stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from 11.57M to 5.49M and how operating and non operating activities have impacted the YEWB stock. One also needs to look at Yew Bio Pharm assets, operating expenses and Yew Bio Pharm free cash flow. The Yew Bio Pharm profit and loss statement shows revenue of $5.49M for 2017 Q4. Revenue has decreased by -52.55% QoQ for YEWB stock.

View and download details of revenue and profits for Yew Bio Pharm for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Yew Bio Pharm Revenues or Net Sales
Cost Of Goods Sold (COGS)12.29M10.81M5.01M7.35M13.24M13.24M14.41M7.22M15.52M3.57M
Yew Bio Pharm Gross Profit
Research & Development Expense----------
Selling General & Admin Expense----------
Income Before Depreciation Depletion Amortization-7.68M-10.28M--1.36M1.11M1.3M1.07M1.32M-
Depreciation Depletion Amortization----------
Non Operating Income-0.15M--0.03M-0.05M-0.04M-0.03M--0.02M--
Interest Expense----------
Yew Bio Pharm Pretax Income
Provision for Income Taxes---------0.04M-
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-7.83M-10.26M--1.43M1.08M1.31M1.05M1.39M-
Extraordinary Items & Discontinued Operations----------
Yew Bio Pharm Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS53.98M54.56M53.04M56.67M51.88M51.89M51.88M51.88M51.88M52.19M
Average Shares used to compute Basic EPS53.98M51.88M51.88M51.88M51.88M51.88M51.88M51.88M51.88M52.16M
Income Before Nonrecurring Items-7.83M-10.26M--1.43M1.08M1.31M1.05M1.39M-
Income from Nonrecurring Items----------
Yew Bio Pharm Earnings Per Share Basic Net
Yew Bio Pharm Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Yew Bio Pharm stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $5.49M for this quarter of 2017 Q4. Our Yew Bio Pharm revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-7.83M for Yew Bio Pharm for 2017 Q4. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the YEWB income statement, one can check the Yew Bio Pharm historical stock prices to check how the price has moved with time.

Yew Bio Pharm Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
PS Ratio (price sales ratio)
Dividend Yield